The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010)

View/Open

Accepted version (405.3Kb)

Accepted version (330.3Kb)

Accepted version (282.2Kb)

Publication Date

2017-05-08

ICR Author

Bliss, Judith

Kernaghan, Sarah

Morden, James Peter

Snowdon, Claire

Author

Bliss, J

Kernaghan, S

Fribbens, C

Stevenson, L

Morden, J

Snowdon, C

Macpherson, I

Wardley, A

Roylance, R

Baird, R

Type

Other

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/873

Collections

• Clinical Studies

Licenseref URL

http://www.rioxx.net/licenses/all-rights-reserved

Funder

The Institute of Cancer Research (Grant ID: Unspecified)

Subject

Science & Technology

Life Sciences & Biomedicine

Medicine, Research & Experimental

Research & Experimental Medicine

Research team

Clinical Trials & Statistics Unit

Language

English

License start date

2017-05-08

Citation

TRIALS, 2017, 18 pp. ? - ? (1)

Publisher

BIOMED CENTRAL LTD